Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Distribution and properties of a mammalian soluble epoxide hydrase.

Literature DB >> 7362652

Distribution and properties of a mammalian soluble epoxide hydrase.

S S Gill, B D Hammock.

Abstract

Entities: Species

Mesh：

Substances：
Epoxide Hydrolases

Year: 1980 PMID： 7362652 DOI： 10.1016/0006-2952(80)90518-3

Source DB: PubMed Journal: Biochem Pharmacol ISSN： 0006-2952 Impact factor: 5.858

Keyword Cloud
Cited

× No keyword cloud information.

38 in total

Review 1. Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

Authors: Hong C Shen; Bruce D Hammock
Journal: J Med Chem Date: 2012-01-17 Impact factor: 7.446

2. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase.

Authors: Hsin-Han Hou; Bruce D Hammock; Kou-Hui Su; Christophe Morisseau; Yu Ru Kou; Susumu Imaoka; Ami Oguro; Song-Kun Shyue; Jin-Feng Zhao; Tzong-Shyuan Lee
Journal: Cardiovasc Res Date: 2011-11-08 Impact factor: 10.787

3. In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s.

Authors: Zhican Wang; Ying Fang; Juli Teague; Hansen Wong; Christophe Morisseau; Bruce D Hammock; Dan A Rock; Zhengping Wang
Journal: Drug Metab Dispos Date: 2017-04-20 Impact factor: 3.922

Review 4. Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders.

Authors: Sydney Zarriello; Julian P Tuazon; Sydney Corey; Samantha Schimmel; Mira Rajani; Anna Gorsky; Diego Incontri; Bruce D Hammock; Cesar V Borlongan
Journal: Prog Neurobiol Date: 2018-11-14 Impact factor: 11.685

5. Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation.

Authors: Yang-Ming Yang; Dong Sun; Sharath Kandhi; Ghezal Froogh; Jian Zhuge; Weihua Huang; Bruce D Hammock; An Huang
Journal: Proc Natl Acad Sci U S A Date: 2018-01-02 Impact factor: 11.205

6. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.

Authors: Matthew L Edin; Behin Gholipour Hamedani; Artiom Gruzdev; Joan P Graves; Fred B Lih; Samuel J Arbes; Rohanit Singh; Anette C Orjuela Leon; J Alyce Bradbury; Laura M DeGraff; Samantha L Hoopes; Michael Arand; Darryl C Zeldin
Journal: J Biol Chem Date: 2018-01-03 Impact factor: 5.157

Distribution and properties of a mammalian soluble epoxide hydrase.

Review 1. Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

2. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase.

3. In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s.

Review 4. Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders.

5. Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation.

6. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.

Review 7. The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain.

8. Cytosolic epoxide hydrolase in humans: development and tissue distribution.

Review 9. Soluble epoxide hydrolase: gene structure, expression and deletion.

10. Inhibition of the soluble epoxide hydrolase by tyrosine nitration.